Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
GenFleet Therapeutics and Merck Enter into Trial Collaboration to Initiate Study Investigating Combination Therapy of GFH925 (KRAS G12C inhibitor) and ERBITUX® (cetuximab)
2022-12-19 19:00
TG ImmunoPharma (TGI) announces FDA clearance of IND application for TGI-2, a novel anti-PVRIG therapeutic antibody
2022-12-17 21:30
Possible Breakthrough in Cardiovascular Disease Diagnostics for the United States
2022-12-16 16:04
Zhejiang Doer Biologics Announces Clinical Trial Collaboration with MSD to Evaluate DR30303 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Gastric or Gastroesophageal Junction Cancer
2022-12-16 09:00
WuXi Biologics (Shanghai) Co., Ltd. Removed from the U.S. Commerce Department's Unverified List
2022-12-16 08:44
Jacobio's KRAS G12C Inhibitor JAB-21822 was Granted Breakthrough Therapy Designations by China CDE
2022-12-16 08:42
EmeTerm Enters Walmart and Best Buy with New Technology
2022-12-16 02:30
China Pharma Holdings, Inc. Announced that several products are included in the Catalogue of Medicines for People Infected with COVID-19
2022-12-15 21:00
Duality announced the appointment of Dr. Pasi A. Jänne as Member of SAB
2022-12-15 21:00
Lunit AI Can Help Tuberculosis Screening in Prisons, as Published in The Lancet Regional Health - Americas
2022-12-15 21:00
BIORCHESTRA receives Citation from the Korean Minister of Trade, Industry, and Energy
2022-12-15 21:00
Actinogen announces first patient treated in depression and cognitive impairment Phase 2 clinical trial
2022-12-14 21:52
E-Home Household Services Holdings Limited's subsidiary Zhong Run Launches Cloud Pharmacy Service to Address New Situation of Epidemic Prevention and Control
2022-12-14 21:30
Hovione and GEA announce a strategic collaboration to advance Continuous Tableting
2022-12-14 21:00
SK Biopharmaceuticals Unveils Vision for Digital Healthcare
2022-12-14 10:00
Sirnaomics Executive Director Dr. Xiaochang Dai to Deliver Keynote Speech at BIOHK2022
2022-12-14 01:40
Biosion Announces Research Collaboration with ImmunoGen to Create Novel Antibody-Drug Conjugates
2022-12-13 18:00
Live from ASH 2022 | Ascentage Pharma Presents Latest Data of APG-2575, Including Encouraging Results of the Combination with BTKi in Patients with R/R CLL/SLL
2022-12-13 17:39
Epidemic: Modified approach ensures maximum benefit
2022-12-13 11:42
Versius adopted for gynaecological and urogynaecological procedures at Frances Perry House
2022-12-13 07:00
1
123
124
125
126
127
801